Innova Captab P/B Ratio
Innova Captab P/B ratio. Innova Captab (INNOVACAP) P/B ratio is 6.67 (High), book value per share ₹191.40 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. Analyse INNOVACAP FII DII holdings to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
INNOVACAP P/B Ratio — Valuation Insights & Book Value Analysis
Innova Captab price-to-book ratio interpretation, valuation status and historical context — current P/B 6.67 (High). For live price, earnings yield and the full fundamental profile, see Innova Captab share price today.
- Stock appears overvalued with PB of 6.67, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of 0.01
Innova Captab P/B Ratio Historical Trend
INNOVACAP annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View INNOVACAP 52-week chart for the annual high/low range and current price position.
INNOVACAP Historical P/B Ratio — Book Value Per Share & Year-End Price
Innova Captab annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 5.98 | ₹191.4 | ₹1145.40 | ₹1,091 | High |
| 2025 | 4.28 | ₹168.25 | ₹720.10 | ₹959 | High |
| 2024 | 7.65 | ₹145.79 | ₹1115.40 | ₹831 | High |
| 2023 | 9.38 | ₹57.71 | ₹541.40 | ₹277 | High |
INNOVACAP vs Healthcare Peers — P/B Ratio Comparison
Innova Captab P/B 6.67 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |